A One-Day Melanoma Refresh with Cleveland Clinic Experts

Brush up on the latest advances in melanoma treatment with a fast, free and expert-led program tailored to healthcare professionals. On Aug. 24, Brian Gastman, MD, Professor of Surgery at Cleveland Clinic Lerner College of Medicine, and Ahmad Tarhini, MD, PhD, Professor of Medicine at Cleveland Clinic Lerner College of Medicine, will chair the third annual Melanoma Symposium in partnership with Merck. Experts from Cleveland Clinic and other organizations will address important advances in the treatment of melanoma in this complimentary one-day symposium. The program consists of case-based discussions of treatment options for melanoma, including:

Major Updates in Melanoma with Brian Gastman, MD

Melafind, Dermoscopy, Mole Mapping with Philip Bailin, MD

Castle Biosciences & Familial Genetics with Joshua Arbesman, MD

Treatment Side Effects with Suzanne McGettigan, CNP

Autoimmune Side Effects from Immunotherapy with Joanna Brell, MD

Sentinel Node Biopsies & Completion LN Dissection with Alok Vij, MD

Standard of Care Combination Data with Pauline Funchain, MD

Dermal Primary v. In-Transit Mets with Bruce Averbook, MD

Adjuvant Therapy with Ahmad Tarhini, MD, PhD

Details and registration information

The symposium will take place on Friday, Aug. 24 from 9:30 a.m. – 4 p.m. at the InterContinental Hotel & Conference Center, 9801 Carnegie Avenue, Cleveland. Lunch is provided. Space is limited, so register with Becky Habecker, Melanoma Program Manager, at habeckb@ccf.org or 216.445.2612.

Image: Confocal microscopy image using SmartFlare™ Detection Probes to isolate nodal-positive melanoma cells from a heterogeneous population. The image shows that nodal-positive cells (blue) are also positive for CD-133 (green). Source: National Cancer Institute.